Zesen Gao

Zesen Gao

Auto-generated profile, based on publicly available information

Zesen Gao

The University of Hong Kong Libraries, The University of Hong Kong, Hong Kong SAR, China (Hong Kong)

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2026 in BMJ Open
Verified
Journal Article
Open access
WCWill Lung Chan
Will Lung Chan
ZGZesen Gao
Zesen Gao
ACArthur Liu Chuxi
Arthur Liu Chuxi
TRTimothy Rainer
Timothy Rainer
WTWilson Wing Chung Tang
Wilson Wing Chung Tang
ZLZohar Lederman
Zohar Lederman
Introduction: Loneliness and social isolation are critical public health issues linked to significant adverse health outcomes and increased healthcare utilisation, including visits to the emergency department (ED). The ED often serves as a primary societal safety net, providing care for vulnerable populations who may be disproportionately affected by these conditions. In fact, loneliness and social isolation might be the underlying reasons they presented to the ED in the first place either consciously or not. For such individuals, the ED encounter may represent a rare point of human contact, yet the stressful and depersonalising nature of the ED environment may paradoxically exacerbate their sense of isolation. Furthermore, ED staff may lack the training and awareness of the scope of the problem to properly screen for loneliness and address it. Yet, the compounded impact of the ED experience on lonely or socially isolated patients and the relationship between loneliness and healthcare utilisation remains poorly understood. This paper presents a protocol for a scoping review designed to systematically map the existing evidence on the experiences of these patients and the perspectives of the clinicians who care for them. Methods and analysis: This scoping review will be conducted following the Arksey and O’Malley methodological framework in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The findings will be reported according to the Extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (PRISMA-S; see online supplemental file 1). A comprehensive search will be performed across five electronic databases (PubMed, Embase, Scopus, Web of Science, CNKI) and grey literature sources. Studies published in English or Chinese that address loneliness or social isolation in the ED context, from the perspective of adult or paediatric patients or clinical staff, will be included. A novel, artificial intelligence (AI)-assisted screening process will be utilised for initial relevance assessment, followed by full manual screening and data extraction by two independent reviewers to ensure rigour and mitigate bias. Findings will be synthesised using a narrative approach and thematic analysis to identify key concepts, themes and existing gaps in the literature. Ethics and dissemination: As this study synthesises data from previously published literature, it does not require formal ethical approval. The findings will be disseminated through a manuscript submitted to a peer-reviewed, open-access journal. The aim is to provide an evidence-based roadmap to guide future research, inform policy and support the development of interventions designed to improve care and outcomes for this vulnerable population within the acute care setting. Registration number: The review has been registered at Open Science Framework, DOI 10.17605/OSF.IO/MBVSR.

10 July 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CLChengfei Li
Chengfei Li
ZDZonglin Dai
Zonglin Dai
WTWing Chung Tang
Wing Chung Tang
ZGZesen Gao
Zesen Gao
VCVivien Kin Yi Chan
Vivien Kin Yi Chan
XLXue Li
Xue Li
Background: Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by bone fragility and recurrent fractures. Emerging biologics demonstrate promise by targeting bone-remodeling pathways, yet evidence for their efficacy and safety remains fragmented and heterogeneous, and no prior systematic review in OI has incorporated artificial intelligence (AI) to synthesize it. Objective: This study aims to systematically evaluate the efficacy and safety of novel biologics in patients with OI using an AI-assisted workflow for evidence synthesis. Methods: We conducted a systematic review and meta-analysis of interventional trials of denosumab, setrusumab, teriparatide, romosozumab, and fresolimumab. Data were retrieved from PubMed, Web of Science, Embase, ScienceDirect, the Cochrane Library, and ClinicalTrials.gov up to December 1, 2025. Eligible studies enrolled individuals with OI, reported areal bone mineral density (aBMD) and/or fractures, and were randomized, nonrandomized, or single-arm studies; case series were excluded. As a methodological feature, GPT-4o was integrated into the workflow to perform a parallel 2-stage screening (title/abstract and full text) and to assist with risk of bias assessment using an adapted Cochrane RoB 2 tool. The primary outcome, percentage change in aBMD, was synthesized using a random-effects meta-analysis. GPT-4o was benchmarked against human reviewers using sensitivity, specificity, and weighted Cohen κ. Results: Thirteen trials (n=684) were systematically reviewed, of which 10 (n=333) contributed to meta-analyses. In children, denosumab produced the greatest 12-month increase in lumbar spine aBMD (25.49%, 95% CI 17.14%‐33.84%). In adults, setrusumab at 12 months yielded the highest improvement (9.38%, 95% CI 6.5%‐12.26%). Across trials, no biologic significantly reduced fracture incidence compared to bisphosphonates. Safety profiles varied: denosumab was associated with a high risk of hypercalcemia in children (30.95%), whereas setrusumab had no treatment-related serious adverse events. AI achieved high sensitivity in abstract (97.4%) and full-text (88.9%) screening, and reduced total screening time by over 95%. Although there was substantial agreement with humans in the quality assessment (Cohen κ=0.778, 95% CI 0.710‐0.846), the model exhibited optimism and positional biases due to reliance on probabilistic language patterns rather than structured clinical reasoning. Conclusions: This review is the first to synthesize and quantitatively compare skeletal outcomes across multiple biologics in OI with an AI-assisted review workflow. Denosumab and setrusumab demonstrate promising efficacy in improving lumbar spine aBMD across ages, although current evidence does not support superior fracture reduction over bisphosphonates. GPT-4o can substantially accelerate evidence synthesis but should be deployed with explicit human oversight in tasks requiring contextual understanding and clinical reasoning. These findings should be interpreted cautiously given the small and heterogeneous trial base. Taken together, our workflow presented how evidence synthesis may be scaled and operationalized in real-world rare disease research.

23 December 2025 in The Gerontologist
Verified
Journal Article
Open access
HLHoward Haochu Li
Howard Haochu Li
WTWilson Wing Chung Tang
Wilson Wing Chung Tang
HLHeman Lok Hei Leung
Heman Lok Hei Leung
ZGZesen Gao
Zesen Gao
KCKitman Chan
Kitman Chan
Weiqun LOUWeiqun LOU
Weiqun LOU
Background and Objectives: This review focuses on tools used in dementia diagnostic disclosure, particularly from family caregivers’ perspectives. With dementia affecting millions globally, caregivers face challenges needing clear information and assistance. The review aims to (a) identify tools used, (b) assess caregivers’ preferences and challenges, and (c) highlight gaps to enhance communication strategies in dementia care. Research Design and Methods: This systematic review, adhering to the PRISMA guidelines and registered with PROSPERO (CRD42024557806), synthesized evidence from 9 studies on tools for dementia disclosure, with a focus on family caregiver perspectives. A comprehensive search of 8 databases up to September 16, 2025, combined large language model-assisted screening and human review to identify qualitative, quantitative, and mixed-methods studies. Thematic synthesis analyzed caregiver preferences, tool effectiveness, and practice gaps. Results: Across 5 countries (United Kingdom, Australia, United States, Denmark, the Netherlands), written materials were universally valued (e.g., 80%–95% satisfaction), with visual aids and brain images less common but effective when used. Caregivers preferred direct, comprehensive information (e.g., 98% sought details about behavior and psychological symptoms of dementia) delivered face-to-face, with written backups, although retention challenges (e.g., 61% recall) and inconsistent tool provision persisted. Gaps included limited visual aid adoption and poor postdiagnostic support, highlighting unmet needs. Discussion and Implications: This review highlights the importance of tools in supporting caregivers during dementia disclosure and calls for the development of a standardized Dementia Disclosure Evaluation Tool. Despite limitations (e.g., small sample sizes, urban bias), the findings lay the groundwork for improving caregiver support and guiding future research in diverse contexts.